Tapentadol (Nucynta Extended-Release, Nucynta Ir) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Oct 27, 2026
Some Tapentadol products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 11, 2026.
An opioid pain reliever used to treat moderate to severe pain.
Products affected
1 / 8
In shortage since
Oct 5, 2026
Est. full return
Nov 11, 2026
Reports on file
24
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
NUCYNTA EXTENDED-RELEASE
250MG · TABLET (EXTENDED-RELEASE) · KNIGHT THERAPEUTICS INC.
DIN 02415615 · since Oct 5, 2026, est. end Nov 11, 2026 · Delay in shipping of the drug.
DIN 02415593 · ended Dec 7, 2022 · Delay in shipping of the drug.
Showing 12 of 24 reports. All reports are on file with Health Canada.
What's happening
Tapentadol is currently affected by an active shortage report filed with Health Canada by KNIGHT THERAPEUTICS INC..
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Tapentadol is classified under “OPIOIDS” (ATC N02AX).
Recent changes
Oct 27, 2026
Status changed
Oct 5, 2026
New report filed
Common questions
What is Tapentadol used for?
An opioid pain reliever used to treat moderate to severe pain.
When will Tapentadol be back in stock in Canada?
The latest manufacturer estimate is Nov 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Tapentadol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.